Standard classification of glomerular diseases is based on histopathologic abnormalities.
The recent application of proteomic technologies has resulted in paradigm changes in the …

Chronic kidney disease accounts for a significant portion of many national health‐care
budgets. In this viewpoint, we highlight recent advances in urinary proteomic analyses that …

The choice of treatment for primary nephrotic syndrome depends on the pathologic type of
the disorder. Renal biopsy is necessary for a definitive diagnosis, but it is burdensome for …

Diabetic nephropathy (DN) is a serious complication of diabetes caused by changes in the
structure and function of the kidneys. It is important to detect diagnostic biomarkers of DN at …

Diabetic kidney disease (DKD) is one the major complications of diabetes and has become
the most common cause of chronic kidney disease worldwide [1, 2]. The pathogenesis of …

Precision medicine is since long an ongoing refinement of classical medicine, integrating
improved and more detailed pathophysiological understanding with rapid technological …

Kidney damage can be induced by ischemia, autoimmune diseases, hypertension, allograft
rejection, metabolic or genetic disorders, infections or toxins. The influence of these factors …

The traditional chronic kidney disease (CKD) biomarkers (eGFR based on serum creatinine,
sex and age and albuminuria) cannot predict a patient's individual risk for developing …

Diabetic nephropathy (DN) is one of the major microvascular complications of diabetes and
it is defined as a rise in the urinary albumin excretion (UAE) rate and abnormal renal …

The analysis of the urinary proteome is a potential source of information regarding the
kidney's physiopathology. A clear knowledge of the protein composition of normal urine is …